Knokke-Heist (Belgium), 10 December 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) is committed to advancing oral health solutions that enhance patient well-being. Today, the company is pleased to announce a significant milestone: the successful certification of NitrAdine® Disinfecting Tablets under the stringent European Union’s Medical Device Regulation (MDR), marking a new chapter in its pursuit of excellence.
Knokke-Heist (Belgium), 9 December 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) is committed to advancing oral health solutions that enhance patient well-being. Today, the company is pleased to announce a significant milestone: the successful certification of NitrAdine® Disinfecting Tablets under the stringent European Union’s Medical Device Regulation (MDR), marking a new chapter in its pursuit of excellence.
Knokke-Heist (Belgium), 28 November 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) and Group pharmaceuticals Ltd are pleased to announce a strategic alliance with a license agreement on the NitrAdine® formulation to manufacture and distribute in India the bonyf products NitrAdine® denture cleansing & disinfecting tablets.
Ghent (Belgium), 24 October 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) PerioTabs® is proud to introduce its groundbreaking 10-day treatment brushing solution based on the NitrAdine® formula.
Ghent (Belgium), 19 September 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) presents its 2023 financial statements, approved by its Board of Directors and audited by its Statutory Auditors.
Ghent (Belgium), 2 September 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) and bonyf R&D team are excited to introduce a scientifically advanced formulation designed to provide rapid relief from the discomfort associated with heel and finger cracks.
Ghent (Belgium), 9 August 2024, 6:00 p.m.; bonyf NV (Ticker: MLBON) is proud to highlight the exceptional efficacy of NitrAdine®, a leading product in the field of dental hygiene. Classified as a Class IIb medical device, NitrAdine® complies with the rigorous European Standards ensuring the highest level of safety and efficacy.
Ghent (Belgium), 18 July 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) is excited to highlight the exceptional capabilities of our Research and Development (R&D) team, whose innovative work has brought Olivafix® Gold to the forefront of denture adhesive technology.
Knokke (Belgium), 28 June 2024, 6:00 p.m; bonyf NV (Ticker: MLBON) presents its 2023 financial statements, approved by its Board of Directors and audited by its Statutory Auditors.
Ghent (Belgium), 7 June 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) is proud to reaffirm our commitment to R&D, as well as to highlight the proven effectiveness of our unique fast pain-relief mouth ulcer cream AphtoFix®.
